Tenofovir vs Entecavir on the Prognosis of Patients With Hepatitis B Virus-Related Hepatocellular Carcinoma After Liver Resection: The Role of HBsAg Levels
TDF treatment was superior to ETV treatment in improving RFS and OS of HBV-related HCC patients with high HBsAg level after liver resection. Even after controlling for survival competing events, the advantage of TDF treatment remained. Our findings may better help clinicians to assign individualized antiviral regimens to patients with HBV-related HCC after liver resection.
Authors
- Wenjing Qi (ORCID: https://orcid.org/0000-0003-2424-7422)
- Zhancheng Qiu (ORCID: https://orcid.org/0009-0004-1749-3558)
- Tian‐Fu Wen (ORCID: https://orcid.org/0000-0002-1995-554X)
- Junyi Shen (ORCID: https://orcid.org/0009-0005-7426-6527)
- Chuan Li (ORCID: https://orcid.org/0000-0001-8098-1715)
- Yueqing Xu
Institutions
- Sichuan University (CN)
- West China Hospital of Sichuan University (CN)
Publication Details
- Journal
- Clinical and Translational Gastroenterology
- Published
- 2025-01-10
- DOI
- https://doi.org/10.14309/ctg.0000000000000814
- Citations
- 2
- Primary Topic
- Hepatitis B Virus Studies
- Type
- article
- Field-Weighted Citation Impact
- 2.71